Shinseikai Medical Group

Shinseikai Medical Group is a prominent Japanese medical corporation specializing in clinical research and comprehensive healthcare services. The organization is globally recognized for its expertise in conducting Phase 1 clinical trials through its dedicated facilities, including the Hakata Clinic in Fukuoka and the P-One Clinic in Tokyo. These centers provide a highly controlled environment for first-in-human studies, pharmacokinetic assessments, and bioequivalence testing for international pharmaceutical clients. In addition to its research capabilities, the group operates several hospitals and clinics that offer specialized medical care, rehabilitation, and nursing services. Shinseikai plays a critical role in the Japanese drug development ecosystem by bridging the gap between laboratory research and clinical application. The group is committed to maintaining high standards of Good Clinical Practice (GCP) to ensure data integrity and participant safety.